These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9073026)

  • 41. Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients.
    Huey ED; Mirza N; Putnam KT; Soares H; Csako G; Levy JA; Copenhaver B; Cohen RM; Sunderland T
    Dement Geriatr Cogn Disord; 2006; 22(1):48-53. PubMed ID: 16682793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal fluid apo E and apo A-I concentrations in early- and late-onset Alzheimer's disease.
    Song H; Saito K; Seishima M; Noma A; Urakami K; Nakashima K
    Neurosci Lett; 1997 Aug; 231(3):175-8. PubMed ID: 9300650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ε3/4 genotype of the apolipoprotein E is associated with higher risk of Alzheimer's disease in patients with type 2 diabetes mellitus.
    Tang Y; Li YM; Zhang M; Chen YQ; Sun Q
    Gene; 2019 Jun; 703():65-70. PubMed ID: 30890475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
    Vijayaraghavan S; Maetzler W; Reimold M; Lithner CU; Liepelt-Scarfone I; Berg D; Darreh-Shori T
    Alzheimers Dement; 2014 Sep; 10(5):530-540.e1. PubMed ID: 23978325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease.
    Glöckner F; Meske V; Ohm TG
    Neuroscience; 2002; 114(4):1103-14. PubMed ID: 12379263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apolipoprotein E genotype in sporadic early- and late-onset Alzheimer's disease.
    Masullo C; Daniele A; Seripa D; Filippini V; Gravina C; Carbone G; Gainotti G; Fazio VM
    Dement Geriatr Cogn Disord; 1998; 9(3):121-5. PubMed ID: 9621997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.
    Martinez M; Campion D; Brice A; Hannequin D; Dubois B; Didierjean O; Michon A; Thomas-Anterion C; Puel M; Frebourg T; Agid Y; Clerget-Darpoux F
    Arch Neurol; 1998 Jun; 55(6):810-6. PubMed ID: 9626772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease.
    Sorbi S; Nacmias B; Forleo P; Latorraca S; Gobbini I; Bracco L; Piacentini S; Amaducci L
    Neurosci Lett; 1994 Aug; 177(1-2):100-2. PubMed ID: 7824157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid detection of apolipoprotein E genotypes in Alzheimer's disease using polymerase chain reaction-single strand conformation polymorphism.
    Kamruecha W; Chansirikarnjana S; Nimkulrat E; Udommongkol C; Wongmek W; Thangnipon W
    Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):793-7. PubMed ID: 17121308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.
    Lautner R; Insel PS; Skillbäck T; Olsson B; Landén M; Frisoni GB; Herukka SK; Hampel H; Wallin A; Minthon L; Hansson O; Blennow K; Mattsson N; Zetterberg H
    Alzheimers Res Ther; 2017 Oct; 9(1):87. PubMed ID: 29061195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.
    Galasko D; Chang L; Motter R; Clark CM; Kaye J; Knopman D; Thomas R; Kholodenko D; Schenk D; Lieberburg I; Miller B; Green R; Basherad R; Kertiles L; Boss MA; Seubert P
    Arch Neurol; 1998 Jul; 55(7):937-45. PubMed ID: 9678311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. APOE genetic variants and apoE, miR-107 and miR-650 levels in Alzheimer's disease.
    Prendecki M; Florczak-Wyspianska J; Kowalska M; Ilkowski J; Grzelak T; Bialas K; Kozubski W; Dorszewska J
    Folia Neuropathol; 2019; 57(2):106-116. PubMed ID: 31556571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease.
    Talwar P; Sinha J; Grover S; Agarwal R; Kushwaha S; Srivastava MV; Kukreti R
    J Neurol Sci; 2016 Jan; 360():179-87. PubMed ID: 26723997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.
    Nho K; Kim S; Horgusluoglu E; Risacher SL; Shen L; Kim D; Lee S; Foroud T; Shaw LM; Trojanowski JQ; Aisen PS; Petersen RC; Jack CR; Weiner MW; Green RC; Toga AW; Saykin AJ;
    BMC Med Genomics; 2017 May; 10(Suppl 1):29. PubMed ID: 28589856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
    Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype.
    Liu RY; Zhou JN; van Heerikhuize J; Hofman MA; Swaab DF
    J Clin Endocrinol Metab; 1999 Jan; 84(1):323-7. PubMed ID: 9920102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
    Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease.
    Lefranc D; Vermersch P; Dallongeville J; Daems-Monpeurt C; Petit H; Delacourte A
    Neurosci Lett; 1996 Jul; 212(2):91-4. PubMed ID: 8832646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
    Drigalenko E; Poduslo S; Elston R
    Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.